miocamycin has been researched along with Helicobacter Infections in 1 studies
*Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassotti, G; Demiray-Gürbüz, E; Dore, MP; Manca, A; Massidda, M; Yilmaz, O | 1 |
1 trial(s) available for miocamycin and Helicobacter Infections
| Article | Year |
|---|---|
Miocamycin-containing triple therapy for H. pylori infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Breath Tests; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Miocamycin; Pilot Projects; Treatment Outcome; Urea | 2013 |